{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:58:05Z","timestamp":1777874285538,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004910","name":"Pennsylvania Public Utility Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.reprotox.2025.108920","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T11:52:33Z","timestamp":1744890753000},"page":"108920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluating the safety profile of rosuvastatin in pregnant Wistar rats: Bridging gaps in reproductive safety data"],"prefix":"10.1016","volume":"135","author":[{"given":"Diego","family":"dos Santos Reis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziele Al\u00edcia Batista","family":"Caixeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Pedro Monteiro","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falio C\u00e9sar Gon\u00e7alves Guimar\u00e3es","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monatha Nayara Guimar\u00e3es","family":"Te\u00f3filo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila Cristina Alves","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Silva","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Radif Rassi","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clayson Moura","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilson de Melo","family":"Cruvinel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Jos\u00e9 de Almeida","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-4888","authenticated-orcid":false,"given":"Vanessa Cristiane Santana","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.reprotox.2025.108920_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ogc.2018.01.005","article-title":"Pregnancy in woman with obesity","volume":"45","author":"Dolin","year":"2018","journal-title":"Obstet. Gynecol. Clin. Nort. Am."},{"key":"10.1016\/j.reprotox.2025.108920_bib2","article-title":"Pregnancy care for patients with super morbid obesity","volume":"10","author":"Olerich","year":"2022","journal-title":"Front Pedia"},{"issue":"1","key":"10.1016\/j.reprotox.2025.108920_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/07853890.2022.2159063","article-title":"Inappropriate gestational weight gain impact on maternofetal outcomes in gestational diabetes","volume":"55","author":"Monteiro","year":"2023","journal-title":"Ann. Med"},{"issue":"10","key":"10.1016\/j.reprotox.2025.108920_bib4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11883-021-00957-w","article-title":"Management of hypercholesterolemia in pregnant women with atherosclerotic cardiovascular disease","volume":"23","author":"Thobani","year":"2021","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.reprotox.2025.108920_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2022.11.022","article-title":"Use of statins and other lipid-modifying agents across pregnancy: a nationwide drug utilization study in Norway in 2005-2018","volume":"368","author":"Christensen","year":"2023","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae032","article-title":"Dyslipidaemia management in pregnant patients: a 2024 update","volume":"4","author":"Lewek","year":"2024","journal-title":"Eur. Heart J. Open"},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0264437","article-title":"Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: a meta-analysis of randomized controlled studies","volume":"17","author":"Ah","year":"2022","journal-title":"Plos One"},{"issue":"6","key":"10.1016\/j.reprotox.2025.108920_bib8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s13311-023-01399-9","article-title":"HMG-CoA reductase inhibitors for traumatic brain injury","volume":"20","author":"Katlowitz","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.reprotox.2025.108920_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.phrs.2014.02.003","article-title":"Clinical evidence of statin therapy in nondyslipidemic disorders","volume":"88","author":"Ferri","year":"2014","journal-title":"Pharm. Res"},{"key":"10.1016\/j.reprotox.2025.108920_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2016.02.012","article-title":"Rosuvastatin: beyond the cholesterol-lowering effect","volume":"107","author":"Cortese","year":"2016","journal-title":"Pharm. Res"},{"key":"10.1016\/j.reprotox.2025.108920_bib11","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/82107","article-title":"Immunomodulation: a new role for statins?","volume":"6","author":"Palinski","year":"2000","journal-title":"Nat. Med"},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/1074248408318628","article-title":"An overview of the extra-lipid effects of rosuvastatin","volume":"13","author":"Kostapanos","year":"2008","journal-title":"J. Cardiovasc Pharm. Ther."},{"issue":"7","key":"10.1016\/j.reprotox.2025.108920_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5543\/tkda.2021.21211","article-title":"Pleiotropic effects of statins: new evidences","volume":"49","author":"Okyay","year":"2021","journal-title":"Turk. Kardiyol. Dern. Ars"},{"issue":"6","key":"10.1016\/j.reprotox.2025.108920_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/1471-0528.17393","article-title":"Statins in pre-eclampsia or fetal growth restriction: a systematic review and meta-analysis on maternal blood pressure and fetal growth across species","volume":"130","author":"Meijerink","year":"2023","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.reprotox.2025.108920_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/HYPERTENSIONAHA.123.22457","article-title":"Statins prevent the deleterious consequences of placental chemerin upregulation in preeclampsia","volume":"81","author":"Tan","year":"2024","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.reprotox.2025.108920_bib16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1527-3466.2002.tb00099.x","article-title":"Rosuvastatin: a highly effective new HMGCoA reductase inhibitor","volume":"20","author":"Olsson","year":"2006","journal-title":"Cardiovasc Drug Rev."},{"key":"10.1016\/j.reprotox.2025.108920_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DHPS.S4928","article-title":"Long-term use of rosuvastatin: a critical risk benefit appraisal and comparison with other antihyperlipidemic","volume":"1","author":"Calza","year":"2009","journal-title":"Drug Health Patient Saf."},{"key":"10.1016\/j.reprotox.2025.108920_bib18","unstructured":"US Food and Drug Administration - US Department of Health & Human Services. Drug Approval Package \u2013 Crestor\u00ae (Rosuvastatin Calcium) Company Astra Zeneca Pharmaceuticals. Application No: 021366. Approval Date: 8\/13\/2003. Pharmacology Reviews \u2013 Part 3, 2003. Available from: (\u3008https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2003\/21-366_Crestor_Pharmr_P3.pdf\u3009)."},{"key":"10.1016\/j.reprotox.2025.108920_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.crtox.2020.11.002","article-title":"Short- and long-term effects on reproductive parameters of female Wistar rats after exposure to rosuvastatin starting in pre-puberty","volume":"1","author":"Barros","year":"2020","journal-title":"Curr. Res Toxicol."},{"issue":"7","key":"10.1016\/j.reprotox.2025.108920_bib20","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/jat.3955","article-title":"Effects of isolated or combined exposure to sibutramine and rosuvastatin on reproductive parameters of adult male rats","volume":"40","author":"Silva","year":"2020","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.reprotox.2025.108920_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2014.01.004","article-title":"Delayed reproductive development in pubertal male rats exposed to the hypolipemiant agent rosuvastatin since prepuberty","volume":"44","author":"Leite","year":"2014","journal-title":"Reprod. Toxicol."},{"issue":"17","key":"10.1016\/j.reprotox.2025.108920_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/15287394.2018.1504702","article-title":"Reproductive outcomes in rat female offspring from male rats co-exposed to rosuvastatin and ascorbic acid during pre-puberty","volume":"81","author":"Leite","year":"2017","journal-title":"J. Toxicol. Environ. Health A"},{"key":"10.1016\/j.reprotox.2025.108920_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108717","article-title":"Prolonged exposure to rosuvastatin from pre-puberty to adulthood impairs sperm quality in mice and leads to paternally mediated developmental toxicity","volume":"130","author":"Mello","year":"2024","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.108920_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.autneu.2006.02.025","article-title":"Enteric neuroplasticity evoked by inflammation","volume":"126-127","author":"Vasina","year":"2006","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.reprotox.2025.108920_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121840","article-title":"Long-term and low dose oral malathion exposure causes morphophysiological changes in the colon of rats","volume":"327","author":"Pupim","year":"2023","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.reprotox.2025.108920_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13580","article-title":"Neurochemical characterization of the enteric neurons within the porcine jejunum in physiological conditions and under the influence of bisphenol A (BPA)","volume":"31","author":"Szymanska","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.reprotox.2025.108920_bib27","series-title":"Test No. 414: Prenatal Developmental Toxicity Study, OECD Guidelines for the Testing of Chemicals, Section 4","author":"OECD","year":"2016"},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.reprotox.2025.108920_bib29","series-title":"Anomalias Cong\u00eanitas: Estudos Experimentais","author":"Damasceno","year":"2008"},{"key":"10.1016\/j.reprotox.2025.108920_bib30","series-title":"Teratology \u2013 Principles and Techniques","article-title":"Methods for administering agents and detecting malformations in experimental animals","author":"Wilson","year":"1965"},{"key":"10.1016\/j.reprotox.2025.108920_bib31","series-title":"Teratology, Test Methods for Laboratory Animals","article-title":"Principles and methods of toxicology","author":"Manson","year":"1982"},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/10520298309066773","article-title":"A modified differential stain for cartilage and bone in whole mount preparations of mammalian fetuses and small vertebrates","volume":"58","author":"Kelly","year":"1983","journal-title":"Stains Technol."},{"issue":"5","key":"10.1016\/j.reprotox.2025.108920_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0890-6238(99)00035-0","article-title":"Correlation between maternal toxicity and embryo\/fetal effects","volume":"13","author":"Chahoud","year":"1999","journal-title":"Reprod. Toxicol."},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.reprotox.2009.06.010","article-title":"L.D. Wise, Terminology of developmental abnormalities in common laboratory mammals (version 2)","volume":"28","author":"Makris","year":"2009","journal-title":"Reprod. Toxicol."},{"issue":"2","key":"10.1016\/j.reprotox.2025.108920_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1242\/dev.112.2.517","article-title":"Macrophages in haemopoietic and other tissues of the developing mouse detected by the monoclonal antibody F4\/80","volume":"112","author":"Morris","year":"1991","journal-title":"Development"},{"key":"10.1016\/j.reprotox.2025.108920_bib36","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.3389\/fimmu.2019.01893","article-title":"The mononuclear phagocytic system. Generation of diversity","volume":"10","author":"Gordon","year":"2019","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/tera.1420290312","article-title":"Maternal toxicity: a possible factor in fetal malformations in mice","volume":"29","author":"Khera","year":"1984","journal-title":"Teratology"},{"key":"10.1016\/j.reprotox.2025.108920_bib38","unstructured":"United States Environmental Protection Agency - EPA. Guidelines for Developmental Toxicity Risk Assessment, December 5, 1991."},{"key":"10.1016\/j.reprotox.2025.108920_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.autneu.2024.103176","article-title":"Tributyltin (TBT) toxicity: Effects on enteric neuronal plasticity and intestinal barrier of rats' duodenum","volume":"253","author":"Oliveira","year":"2024","journal-title":"Auton. Neurosci."},{"issue":"17","key":"10.1016\/j.reprotox.2025.108920_bib40","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJM199604253341707","article-title":"The enteric nervous system","volume":"334","author":"Goyal","year":"1996","journal-title":"N. Engl. J. Med"},{"issue":"1-3","key":"10.1016\/j.reprotox.2025.108920_bib41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-1838(00)00127-2","article-title":"Types of neurons in the enteric nervous system","volume":"81","author":"Furness","year":"2000","journal-title":"J. Auton. Nerv. Syst."},{"issue":"3","key":"10.1016\/j.reprotox.2025.108920_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.57.3.4","article-title":"Gastrointestinal function regulation by nitrergic efferent nerves","volume":"57","author":"Toda","year":"2005","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.reprotox.2025.108920_bib43","doi-asserted-by":"crossref","unstructured":"J.M. DeSesso, A.R. Scialli, Bone development in laboratory mammals used in developmental toxicity studies, Birth Defects Res. 110 (15) (2028) 1157-1187. doi:10.1002\/bdr2.1350.","DOI":"10.1002\/bdr2.1350"},{"issue":"6","key":"10.1016\/j.reprotox.2025.108920_bib44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0890-6238(01)00179-4","article-title":"Harmonization of rat fetal skeletal terminology and classification. Report of the third workshop on the terminology in developmental toxicology Berlin, 14 \u2013 16 September 2000","volume":"15","author":"Solecki","year":"2001","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.108920_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.reprotox.2015.06.046","article-title":"Continuing harmonization of terminology and innovations for methodologies in developmental toxicology: Report of the 8th Berlin Workshop on Developmental Toxicity, 14-16 May 2014","volume":"57","author":"Solecki","year":"2015","journal-title":"Reprod. Toxicol."},{"issue":"4","key":"10.1016\/j.reprotox.2025.108920_bib46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/(SICI)1096-9926(199704)55:4<249::AID-TERA5>3.0.CO;2-W","article-title":"Terminology of developmental abnormalities in common laboratory mammals (Version 1)","volume":"55","author":"Wise","year":"1997","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.reprotox.2025.108920_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.reprotox.2008.12.001","article-title":"Harmonization of terminology in developmental toxicology: the quest for a more precise description and a harmonized classification of fetal observations","volume":"27","author":"Paumgartten","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2025.108920_bib48","unstructured":"US Food and Drug Administration. FDA requests removal of strongest warning against using cholesterol-lowering statins during pregnancy; still advises most pregnant patients should stop taking statins. Accessed November 12, 2024. \u3008https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requests-removal-stronge\u3009."},{"issue":"1","key":"10.1016\/j.reprotox.2025.108920_bib49","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjmed.2022.08.029","article-title":"Update on statin use in pregnancy","volume":"136","author":"Poornima","year":"2023","journal-title":"Am. J. Med"},{"key":"10.1016\/j.reprotox.2025.108920_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.reprotox.2024.108820","article-title":"Embryotoxicity of statins and other prescribed drugs with reported off-target effects on cholesterol biosynthesis","volume":"132","author":"Hartley","year":"2025","journal-title":"Reprod. Toxicol."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623825000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:30:39Z","timestamp":1777577439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623825000917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":50,"alternative-id":["S0890623825000917"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.108920","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the safety profile of rosuvastatin in pregnant Wistar rats: Bridging gaps in reproductive safety data","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2025.108920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108920"}}